Status:

COMPLETED

Feasibility Trial of Narrative Exposure Therapy (NET) for Posttraumatic Stress Disorder (PTSD) During Pregnancy

Lead Sponsor:

Rush University Medical Center

Conditions:

Post Traumatic Stress Disorder

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Posttraumatic stress disorder (PTSD) affects up to 35% of pregnant trauma survivors. Moreover, prenatal PTSD rates are up to 4 times higher among communities of color compared to white populations. PT...

Detailed Description

Investigators will conduct a feasibility and acceptability study of Narrative Exposure Therapy (NET) to treat up to 30 pregnant trauma survivors with clinically-significant symptoms of PTSD. Up to 10...

Eligibility Criteria

Inclusion

  • Inclusion:
  • 18 years of age or older
  • Fluent in English
  • History of a DSM-V PTSD criterion A trauma at least 3 months prior to current pregnancy (a person has experienced, witnessed, or been confronted with an event or events that involve actual or threatened death or serious injury, or threat of physical integrity to oneself or others)
  • A score of 33 or higher on the PTSD Checklist for the DSM-V with Life Events Checklist for DSM-5 and Criterion A.
  • Exclusion:
  • Current manic or psychotic symptoms or primary psychotic diagnosis
  • Serious cognitive impairment
  • Concurrent psychotherapy
  • Unstable dose of psychotropic medications (must be stable for 6 weeks)
  • Serious medical complications of pregnancy (e.g., pre-eclampsia, HELLP syndrome, diagnosed fetal anomaly or death, threatened preterm birth, hospitalization for hypertensive disorders of pregnancy, unstable diabetes, premature rupture of membranes, preterm labor)
  • Significant suicidal ideation
  • Current legal actions related to trauma
  • Patient will be 27 gestational weeks or more at the time of the eligibility session

Exclusion

    Key Trial Info

    Start Date :

    February 27 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    May 1 2022

    Estimated Enrollment :

    29 Patients enrolled

    Trial Details

    Trial ID

    NCT04525469

    Start Date

    February 27 2019

    End Date

    May 1 2022

    Last Update

    July 22 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Rush University Medical Center

    Chicago, Illinois, United States, 60612